Literature DB >> 646693

Optic tract syndrome. A review of 21 patients.

P J Savino, M Paris, N J Schatz, L S Orr, J J Corbett.   

Abstract

Twenty-one patients with lesions compromising the optic tract were reviewed. The involvement of the optic tract may be diagnosed in the presence of highly incongruous hemianopia, an afferent pupillary defect, and characteristic atrophy of the optic discs. Behr's pupil, hemianopic pupillary reaction (Wernicke's sign), and associated major neurologic deficits were encountered rarely.

Entities:  

Mesh:

Year:  1978        PMID: 646693     DOI: 10.1001/archopht.1978.03910050352011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

Review 1.  Neurovisual rehabilitation: recent developments and future directions.

Authors:  G Kerkhoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

2.  Wilbrand's knee of the primate optic chiasm is an artefact of monocular enucleation.

Authors:  J C Horton
Journal:  Trans Am Ophthalmol Soc       Date:  1997

3.  Spectral-domain optical coherence tomography detects optic atrophy due to optic tract syndrome.

Authors:  Akiyasu Kanamori; Makoto Nakamura; Yuko Yamada; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-04       Impact factor: 3.117

4.  Tracking posttraumatic hemianopia.

Authors:  Thomas Decramer; Karel Van Keer; Peter Stalmans; Patrick Dupont; Stefan Sunaert; Tom Theys
Journal:  J Neurol       Date:  2017-11-06       Impact factor: 4.849

5.  Band atrophy of the optic nerve: A report on different anatomical locations in three patients.

Authors:  Alberto Gálvez-Ruiz; Nawal Arishi
Journal:  Saudi J Ophthalmol       Date:  2013-01-02

6.  Quantitative Analysis of Macular Inner Retinal Layer Using Swept-Source Optical Coherence Tomography in Patients with Optic Tract Syndrome.

Authors:  Katsutoshi Goto; Atsushi Miki; Tsutomu Yamashita; Syunsuke Araki; Go Takizawa; Kenichi Mizukawa; Yoshiaki Ieki; Junichi Kiryu
Journal:  J Ophthalmol       Date:  2017-06-28       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.